Cargando…

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells

Within the field of cancer research, focus on the study of minimal residual disease (MRD) in the context of carcinoma has grown exponentially over the past several years. MRD encompasses circulating tumour cells (CTCs)—cancer cells on the move via the circulatory or lymphatic system, disseminated tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tachtsidis, A., McInnes, L. M., Jacobsen, N., Thompson, E. W., Saunders, C. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947105/ https://www.ncbi.nlm.nih.gov/pubmed/27189371 http://dx.doi.org/10.1007/s10585-016-9796-8

Ejemplares similares

Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial–Mesenchymal Plasticity
por: McInnes, Linda M., et al.
Publicado: (2015)

Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma
por: Zhao, Lina, et al.
Publicado: (2022)

Minimal residual disease and circulating tumor cells in breast cancer
por: Ignatiadis, Michail, et al.
Publicado: (2011)

Clinical utility of serial analysis of circulating tumour cells for detection of minimal residual disease of metastatic nasopharyngeal carcinoma
por: Ko, Josephine Mun-Yee, et al.
Publicado: (2020)

Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
por: Slade, M J, et al.
Publicado: (2009)

Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2016)

Personalised circulating tumour DNA assay with large-scale mutation coverage for sensitive minimal residual disease detection in colorectal cancer
por: Ryoo, Seung-Bum, et al.
Publicado: (2023)

Disseminated cutaneous immunoglobulin M macroglobulinosis associated with cryoglobulinemia and minimal residual disease of Waldenström macroglobulinemia
por: Fayne, Rachel, et al.
Publicado: (2019)

The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
por: Payne, R E, et al.
Publicado: (2012)

Heterogeneity of miR-10b expression in circulating tumor cells
por: Gasch, Christin, et al.
Publicado: (2015)

Early postoperative MRI overestimates residual tumour after resection of gliomas with no or minimal enhancement
por: Belhawi, Sinan M. K., et al.
Publicado: (2011)

Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models
por: Hassan, Sara, et al.
Publicado: (2022)

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II–IIIA NSCLC patients
por: Vessies, Daan C. L., et al.
Publicado: (2022)

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
por: Kurtz, David M., et al.
Publicado: (2021)

Circulating and Disseminated Tumour Cells in Breast Carcinoma: Report from the Consensus Conference on Tumour Cell Dissemination during the 38th Annual Meeting of the German Society of Senology, Berlin, 14 June 2018
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
por: Rzepiel, Andrea, et al.
Publicado: (2019)

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
por: Semenkovich, Nicholas P, et al.
Publicado: (2023)

Impact of obesity on breast cancer recurrence and minimal residual disease
por: Ecker, Brett L., et al.
Publicado: (2019)

Metabolic memory underlying minimal residual disease in breast cancer
por: Radic Shechter, Ksenija, et al.
Publicado: (2021)

Tumour invasion and dissemination
por: Lusby, Ryan, et al.
Publicado: (2022)

Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer
por: Benoy, I H, et al.
Publicado: (2006)

Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma
por: Hesse, E, et al.
Publicado: (2005)

Disseminated tumour cells as a prognostic biomarker in colorectal cancer
por: Flatmark, K, et al.
Publicado: (2011)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination.
por: Koscielny, S., et al.
Publicado: (1984)

Personalized analysis of minimal residual cancer cells in peritoneal lavage fluid predicts peritoneal dissemination of gastric cancer
por: Zhao, Dongbing, et al.
Publicado: (2021)

How UK internet websites portray breast milk expression and breast pumps: a qualitative study of content
por: McInnes, Rhona J, et al.
Publicado: (2015)

Disseminating information systems across the Atlantic: Collaboration between U.K. National Health Service and U.S. Department of Veterans Affairs
por: McInnes, D Keith, et al.
Publicado: (2015)

Impact of tumour size on axillary involvement and distant dissemination in breast cancer
por: Koscielny, S, et al.
Publicado: (2009)

Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients
por: Hartkopf, Andreas D., et al.
Publicado: (2016)

The therapeutic potential of targeting minimal residual disease in melanoma
por: Patel, Riyaben P, et al.
Publicado: (2023)

Disseminated Infections: A Clinical Overview
por: Ellis, Simon, et al.
Publicado: (2015)

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Peng, Yan, et al.
Publicado: (2021)

Minimal residual disease assessment of papillary thyroid carcinoma through circulating tumor cell‐based cytology
por: Innaro, Nadia, et al.
Publicado: (2022)

Editorial: Circulating molecular biomarkers: next-generation tools for monitoring minimal residual disease in cancer patients
por: Amoozgar, Zohreh, et al.
Publicado: (2023)

Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
por: Cirmena, Gabriella, et al.
Publicado: (2020)

Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours
por: Reiman, A, et al.
Publicado: (2011)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Assessment of Minimal Residual Disease in Ewing Sarcoma
por: Wagner, Lars M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b5pqvp6vm1cededfrin2luhafk